Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotechnology company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system.
Roche is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).
For more information, please visit www.roche.com.
About Roche APAC
Roche established a presence in Asia Pacific in 1925. We now operate in 16 locations across the Asia Pacific region including Australia, New Zealand, Japan and China with a team of more than 5,700 people.
In Asia Pacific, we are passionate about empowering patients with the power of knowing, and providing innovations that are designed to address healthcare challenges that emerge now and in the future. With the most comprehensive diagnostics portfolio in the industry, we bring to the market advanced and integrated solutions in diagnostic testing, laboratory efficiency and decision support tools to enable better disease management and improve patient outcomes. Asia Pacific is one of the most diverse regions in the world and represents one of the most complex mixtures of healthcare systems. By partnering with institutions and stakeholders in our locations, we effectively address the needs of these healthcare systems, making Asia Pacific the growth engine for the global diagnostics business.
Diagram magazine is a publication from Roche Diagnostics Asia Pacific that explores the forces transforming healthcare across the Asia Pacific region. Our mission is to document the many ways in which diagnostics impact healthcare, from detection and risk stratification to monitoring and disease management. We also tell the stories of today’s innovators and change-makers who are dreaming of a better tomorrow and fighting to make it happen. From the patients who face difficult questions to laboratories that provide simple answers, we share stories of growth, change, and innovation.
Diagnostics is the bedrock of healthcare and there are many stories to be told.